Skip to main content
Top
Published in: BMC Infectious Diseases 1/2014

Open Access 01-12-2014 | Research article

Estimating the under-reporting of norovirus illness in Germany utilizing enhanced awareness of diarrhoea during a large outbreak of Shiga toxin-producing E. coli O104:H4 in 2011 – a time series analysis

Authors: Helen Bernard, Dirk Werber, Michael Höhle

Published in: BMC Infectious Diseases | Issue 1/2014

Login to get access

Abstract

Background

Laboratory-confirmed norovirus illness is reportable in Germany since 2001. Reported case numbers are known to be undercounts, and a valid estimate of the actual incidence in Germany does not exist. An increase of reported norovirus illness was observed simultaneously to a large outbreak of Shiga toxin-producing E. coli O104:H4 in Germany in 2011 – likely due to enhanced (but not complete) awareness of diarrhoea at that time. We aimed at estimating age- and sex-specific factors of that excess, which should be interpretable as (minimal) under-reporting factors of norovirus illness in Germany.

Methods

We used national reporting data on laboratory-confirmed norovirus illness in Germany from calendar week 31 in 2003 through calendar week 30 in 2012. A negative binomial time series regression model was used to describe the weekly counts in 8∙2 age-sex strata while adjusting for secular trend and seasonality. Overall as well as age- and sex-specific factors for the excess were estimated by including additional terms (either an O104:H4 outbreak period indicator or a triple interaction term between outbreak period, age and sex) in the model.

Results

We estimated the overall under-reporting factor to be 1.76 (95% CI 1.28-2.41) for the first three weeks of the outbreak before the outbreak vehicle was publicly communicated. Highest under-reporting factors were here estimated for 20–29 year-old males (2.88, 95% CI 2.01-4.11) and females (2.67, 95% CI 1.87-3.79). Under-reporting was substantially lower in persons aged <10 years and 70 years or older.

Conclusions

These are the first estimates of (minimal) under-reporting factors for norovirus illness in Germany. They provide a starting point for a more detailed investigation of the relationship between actual incidence and reporting incidence of norovirus illness in Germany.
Appendix
Available only for authorised users
Literature
1.
go back to reference Glass RI, Parashar UD, Estes MK: Norovirus gastroenteritis. N Engl J Med. 2009, 361 (18): 1776-1785. 10.1056/NEJMra0804575.CrossRefPubMed Glass RI, Parashar UD, Estes MK: Norovirus gastroenteritis. N Engl J Med. 2009, 361 (18): 1776-1785. 10.1056/NEJMra0804575.CrossRefPubMed
2.
go back to reference Patel MM, Widdowson MA, Glass RI, Akazawa K, Vinje J, Parashar UD: Systematic literature review of role of noroviruses in sporadic gastroenteritis. Emerg Infect Dis. 2008, 14 (8): 1224-1231. 10.3201/eid1408.071114.CrossRefPubMedPubMedCentral Patel MM, Widdowson MA, Glass RI, Akazawa K, Vinje J, Parashar UD: Systematic literature review of role of noroviruses in sporadic gastroenteritis. Emerg Infect Dis. 2008, 14 (8): 1224-1231. 10.3201/eid1408.071114.CrossRefPubMedPubMedCentral
3.
go back to reference Scallan E, Hoekstra RM, Angulo FJ, Tauxe RV, Widdowson MA, Roy SL, Jones JL, Griffin PM: Foodborne illness acquired in the United States–major pathogens. Emerg Infect Dis. 2011, 17 (1): 7-15. 10.3201/eid1701.P11101.CrossRefPubMedPubMedCentral Scallan E, Hoekstra RM, Angulo FJ, Tauxe RV, Widdowson MA, Roy SL, Jones JL, Griffin PM: Foodborne illness acquired in the United States–major pathogens. Emerg Infect Dis. 2011, 17 (1): 7-15. 10.3201/eid1701.P11101.CrossRefPubMedPubMedCentral
4.
go back to reference Verhoef L, Koopmans M, Van Pelt W, Duizer E, Haagsma J, Werber D, Van Asten L, Havelaar A: The estimated disease burden of norovirus in The Netherlands. Epidemiol Infect. 2013, 141: 496-506. 10.1017/S0950268812000799. doi:10.1017/S0950268812000799CrossRefPubMed Verhoef L, Koopmans M, Van Pelt W, Duizer E, Haagsma J, Werber D, Van Asten L, Havelaar A: The estimated disease burden of norovirus in The Netherlands. Epidemiol Infect. 2013, 141: 496-506. 10.1017/S0950268812000799. doi:10.1017/S0950268812000799CrossRefPubMed
5.
go back to reference Hall AJ, Curns AT, McDonald LC, Parashar UD, Lopman BA: The roles of clostridium difficile and norovirus among gastroenteritis-associated deaths in the United States, 1999–2007. Clin Infect Dis. 2012, 55 (2): 216-223. 10.1093/cid/cis386.CrossRefPubMed Hall AJ, Curns AT, McDonald LC, Parashar UD, Lopman BA: The roles of clostridium difficile and norovirus among gastroenteritis-associated deaths in the United States, 1999–2007. Clin Infect Dis. 2012, 55 (2): 216-223. 10.1093/cid/cis386.CrossRefPubMed
6.
go back to reference Revised case definitions for the submission of evidence of dengue virus and norovirus and morbidity or death from dengue fever and norovirus gastroenteritis [in German]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2011, 54 (2): 246-50. doi: 10.1007/s00103-010-1214-9 Revised case definitions for the submission of evidence of dengue virus and norovirus and morbidity or death from dengue fever and norovirus gastroenteritis [in German]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2011, 54 (2): 246-50. doi: 10.1007/s00103-010-1214-9
7.
go back to reference Annual Epidemiological Report on Notifiable Infectious Diseases in Germany 2011 [in German]. Edited by: Robert Koch Institute. 2012, Berlin (Germany): Robert Koch Institute Annual Epidemiological Report on Notifiable Infectious Diseases in Germany 2011 [in German]. Edited by: Robert Koch Institute. 2012, Berlin (Germany): Robert Koch Institute
8.
go back to reference Tam CC, Rodrigues LC, Viviani L, Dodds JP, Evans MR, Hunter PR, Gray JJ, Letley LH, Rait G, Tompkins DS, O'Brien SJ, IID2 Study Executive Committee: Longitudinal study of infectious intestinal disease in the UK (IID2 study): incidence in the community and presenting to general practice. Gut. 2012, 61 (1): 69-77. 10.1136/gut.2011.238386.CrossRefPubMed Tam CC, Rodrigues LC, Viviani L, Dodds JP, Evans MR, Hunter PR, Gray JJ, Letley LH, Rait G, Tompkins DS, O'Brien SJ, IID2 Study Executive Committee: Longitudinal study of infectious intestinal disease in the UK (IID2 study): incidence in the community and presenting to general practice. Gut. 2012, 61 (1): 69-77. 10.1136/gut.2011.238386.CrossRefPubMed
9.
go back to reference Frank C, Werber D, Cramer JP, Askar M, Faber M, an der Heiden M, Bernard H, Fruth A, Prager R, Spode A, Wadl M, Zoufaly A, Jordan S, Kemper MJ, Follin P, Müller L, King LA, Rosner B, Buchholz U, Stark K, Krause G, HUS Investigation Team: Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany. N Engl J Med. 2011, 365 (19): 1771-1780. 10.1056/NEJMoa1106483.CrossRefPubMed Frank C, Werber D, Cramer JP, Askar M, Faber M, an der Heiden M, Bernard H, Fruth A, Prager R, Spode A, Wadl M, Zoufaly A, Jordan S, Kemper MJ, Follin P, Müller L, King LA, Rosner B, Buchholz U, Stark K, Krause G, HUS Investigation Team: Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany. N Engl J Med. 2011, 365 (19): 1771-1780. 10.1056/NEJMoa1106483.CrossRefPubMed
10.
go back to reference Hilbe J: Negative Binomial Regression. 2011, Cambridge: Cambridge University Press, SecondCrossRef Hilbe J: Negative Binomial Regression. 2011, Cambridge: Cambridge University Press, SecondCrossRef
14.
go back to reference Bernard H, Höhne M, Niendorf S, Altmann D, Stark K: Epidemiology of norovirus gastroenteritis in Germany 2001–2009: eight seasons of routine surveillance. Epidemiol Infect. 2014, 142 (1): 63-74. doi: 10.1017/S0950268813000435. Epub 2013 Mar 21PubMed Bernard H, Höhne M, Niendorf S, Altmann D, Stark K: Epidemiology of norovirus gastroenteritis in Germany 2001–2009: eight seasons of routine surveillance. Epidemiol Infect. 2014, 142 (1): 63-74. doi: 10.1017/S0950268813000435. Epub 2013 Mar 21PubMed
15.
go back to reference Lopman B, Armstrong B, Atchison C, Gray JJ: Host, weather and virological factors drive norovirus epidemiology: time-series analysis of laboratory surveillance data in England and Wales. PLoS One. 2009, 4 (8): e6671-10.1371/journal.pone.0006671.CrossRefPubMedPubMedCentral Lopman B, Armstrong B, Atchison C, Gray JJ: Host, weather and virological factors drive norovirus epidemiology: time-series analysis of laboratory surveillance data in England and Wales. PLoS One. 2009, 4 (8): e6671-10.1371/journal.pone.0006671.CrossRefPubMedPubMedCentral
Metadata
Title
Estimating the under-reporting of norovirus illness in Germany utilizing enhanced awareness of diarrhoea during a large outbreak of Shiga toxin-producing E. coli O104:H4 in 2011 – a time series analysis
Authors
Helen Bernard
Dirk Werber
Michael Höhle
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2014
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-14-116

Other articles of this Issue 1/2014

BMC Infectious Diseases 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine